It does not aim to exhaustively cover all molecular alterations linked to the pathogenesis of IR, or the advancements in understanding insulin signaling components downstream of the INSR, which may be altered in obesity. The gene discussed is INSR; the disease is obesity due to melanocortin 4 receptor deficiency.